India’s 1st Covid Nasal Spray FabiSpray For Treating Adult COVID-19 Patients Launched: Read Details

Glenmark Pharmaceuticals has launched a Nasal Spray containing Nitric Oxide, named FabiSpray, in India to treat adult patients suffering from COVID-19. While addressing the nation in June 2021, Narendra Modi highlighted the government’s new efforts to combat the COVID-19 pandemic. Moreover,
http://dlvr.it/SJk1FX